Sector
PharmaceuticalsOpen
₹51.1Prev. Close
₹53.7Turnover(Lac.)
₹13.27Day's High
₹51.25Day's Low
₹51.0552 Week's High
₹63.8552 Week's Low
₹36.05Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
56.15P/E
17.84EPS
3.01Divi. Yield
01 Sep 2023
12:00 AM
AGM
Announcement Date: 01 Sep, 2023
20 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 11 | 8.02 | 0.5 | 0.42 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 21.27 | 3.27 | 6.38 | 4.95 |
Net Worth | 32.27 | 11.29 | 6.88 | 5.37 |
Minority Interest |
No Record found
No Record found
No Record found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Smiral Ashwinkumar Patel
Non Executive Director
Manishkumar Jasvantlal Patel
Whole-time Director
Tejal Smiral Patel
Non-Exec. & Independent Dir.
Sonu Lalitkumar Jain
Non-Exec. & Independent Dir.
Bhavna Shah
Company Sec. & Compli. Officer
Pratima Singh
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by JFL Life Sciences Ltd
Summary
JFL Life Sciences Ltd. was incorporated as JFL Life Sciences Private Limited on April 25, 2010 as a Private Limited Company under Companies Act, 1956. Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited, on March 3, 2022. The Company primarily manufactures and market pharmaceutical products. Its product portfolio consists of Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and Capsules (general) and Oral Rehydration Solutions (ORS). The Company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care, it has laid a strong R&D foundation and a FDA approved manufacturing facility near Ahmedabad. It also export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. For the purpose of identification equipment / machinery / containers are appropriately labelled to identify the stage of process. In case of tablets, the materials are quarantined after granulation, compression, coating and final packing operations for clearance from Q.A. before pursuing the next stage of process. In case of capsule, the materials are quarantined after mixing, filling and final pa
Read More
What is the JFL Life Sciences Ltd share price today?
The JFL Life Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹51.05 today.
What is the Market Cap of JFL Life Sciences Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of JFL Life Sciences Ltd is ₹56.15 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of JFL Life Sciences Ltd?
The PE and PB ratios of JFL Life Sciences Ltd is 17.84 and 1.66 as of 22 Jul ‘24
What is the 52 Week High and Low of JFL Life Sciences Ltd?
The 52-week high/low is the highest and lowest price at which a JFL Life Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of JFL Life Sciences Ltd is ₹36.05 and ₹63.85 as of 22 Jul ‘24
What is the CAGR of JFL Life Sciences Ltd?
JFL Life Sciences Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 13.17%, 6 Month at 14.99%, 3 Month at 37.69% and 1 Month at 23.45%.
What is the shareholding pattern of JFL Life Sciences Ltd?
The shareholding pattern of JFL Life Sciences Ltd is as follows:
Promoters - 67.47 %
Institutions - 0.00 %
Public - 32.53 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
